Copyright
©The Author(s) 2018.
World J Orthop. Sep 18, 2018; 9(9): 120-129
Published online Sep 18, 2018. doi: 10.5312/wjo.v9.i9.120
Published online Sep 18, 2018. doi: 10.5312/wjo.v9.i9.120
Figure 3 Osteonecrosis of the femoral head treated with prolonged delivery of 500 μg of vascular endothelial growth factor through a pump (t-VEGFpump-μ group).
At 12 wk postoperatively, a well-formed trabecular network is visible, with slightly thickened lamellar trabeculae, and normal marrow cells and adipose tissue (A) in between. A: Few trabeculae are covered by newly formed bone (vT), the presence of nuclei in lacunae is noticed (Obj. × 10, H and E); B: New bone (vT) formation is observed on the surface of some trabeculae (Obj. × 10, TB).
- Citation: Dailiana ZH, Stefanou N, Khaldi L, Dimakopoulos G, Bowers JR, Fink C, Urbaniak JR. Vascular endothelial growth factor for the treatment of femoral head osteonecrosis: An experimental study in canines. World J Orthop 2018; 9(9): 120-129
- URL: https://www.wjgnet.com/2218-5836/full/v9/i9/120.htm
- DOI: https://dx.doi.org/10.5312/wjo.v9.i9.120